Literature DB >> 12820273

Tandem mass spectrometry in the study of fatty acids, bile acids, and steroids.

William J Griffiths1.   

Abstract

Over the last 50 years, the mass spectrometry of lipids has evolved to become one of the most mature techniques in biomolecule analysis. Many volatile and non-polar lipids are directly amenable to analysis by gas-chromatography-mass spectrometry (GC-MS), a technique that combines the unsurpassed separation properties of gas-chromatography with the sensitivity and selectivity of electron ionization mass spectrometry. Less volatile and/or thermally labile lipids can be analyzed by GC-MS, following appropriate sample derivatization. However, many complex lipids are not readily analyzed by GC-MS, and it is these molecules that are the subject of the current review. Since the early 1970s, there have been three outstanding developments in mass spectrometry that are particularly appropriate in lipid analysis; i.e., the introduction of (i) fast atom bombardment (FAB); (ii) electrospray (ES); and (iii) tandem mass spectrometry (MS/MS). The FAB and ES ionization techniques will be discussed in relation to MS/MS, and examples of their application in biochemical studies will be presented. The review will concentrate on the analysis of fatty acids, bile acids, steroid conjugates, and neutral steroids. Copyright 2003 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12820273     DOI: 10.1002/mas.10046

Source DB:  PubMed          Journal:  Mass Spectrom Rev        ISSN: 0277-7037            Impact factor:   10.946


  55 in total

Review 1.  New applications of mass spectrometry in lipid analysis.

Authors:  Robert C Murphy; Simon J Gaskell
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

2.  Production of reliable MALDI spectra with quality threshold clustering of replicates.

Authors:  Matthew T Olson; Jonathan A Epstein; Dan L Sackett; Alfred L Yergey
Journal:  J Am Soc Mass Spectrom       Date:  2011-03-08       Impact factor: 3.109

Review 3.  Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer's disease.

Authors:  Xianlin Han
Journal:  Biochim Biophys Acta       Date:  2010-02-01

Review 4.  Mass spectrometry-based metabolomics.

Authors:  Katja Dettmer; Pavel A Aronov; Bruce D Hammock
Journal:  Mass Spectrom Rev       Date:  2007 Jan-Feb       Impact factor: 10.946

Review 5.  Glycerolipid and cholesterol ester analyses in biological samples by mass spectrometry.

Authors:  Robert C Murphy; Thomas J Leiker; Robert M Barkley
Journal:  Biochim Biophys Acta       Date:  2011-06-26

6.  Quantitative structural multiclass lipidomics using differential mobility: electron impact excitation of ions from organics (EIEIO) mass spectrometry.

Authors:  Takashi Baba; J Larry Campbell; J C Yves Le Blanc; Paul R S Baker; Kazutaka Ikeda
Journal:  J Lipid Res       Date:  2018-03-14       Impact factor: 5.922

Review 7.  Bile acids: analysis in biological fluids and tissues.

Authors:  William J Griffiths; Jan Sjövall
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

Review 8.  Potential mechanisms contributing to sulfatide depletion at the earliest clinically recognizable stage of Alzheimer's disease: a tale of shotgun lipidomics.

Authors:  Xianlin Han
Journal:  J Neurochem       Date:  2007-11       Impact factor: 5.372

9.  Lipidomics analysis of essential fatty acids in macrophages.

Authors:  Oswald Quehenberger; Aaron Armando; Darren Dumlao; Daren L Stephens; Edward A Dennis
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2008-11-08       Impact factor: 4.006

10.  Detection of carbohydrates and steroids by cation-enhanced nanostructure-initiator mass spectrometry (NIMS) for biofluid analysis and tissue imaging.

Authors:  Gary J Patti; Hin-Koon Woo; Oscar Yanes; Leah Shriver; Diane Thomas; Wilasinee Uritboonthai; Junefredo V Apon; Rick Steenwyk; Marianne Manchester; Gary Siuzdak
Journal:  Anal Chem       Date:  2010-01-01       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.